Revolution Medicines, Inc. (RVMDW) Operating income 2018–2025
Revolution Medicines, Inc. (RVMDW) annual operating income history from SEC filings — each fiscal year as reported.
-$1.2BFY2025 · since FY2018: -$40.3M → -$1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.2B | -71.5% |
| FY2024 | -$689.5M | -41.5% |
| FY2023 | -$487.2M | -88.6% |
| FY2022 | -$258.3M | -37.4% |
| FY2021 | -$188.0M | -69.8% |
| FY2020 | -$110.7M | -104.5% |
| FY2019 | -$54.1M | -34.2% |
| FY2018 | -$40.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice